Update on overall prevalence of major birth defects--Atlanta, Georgia, 1978-2005
- PMID: 18185492
Update on overall prevalence of major birth defects--Atlanta, Georgia, 1978-2005
Abstract
Major structural or genetic birth defects affect approximately 3% of births in the United States, are a major contributor to infant mortality, and result in billions of dollars in costs for care. Although the causes of most major birth defects are unknown, concerns have been raised that certain factors, such as an increase in the prevalence of diabetes among women, might result in increased prevalence of birth defects over time. This report updates previously published data from the Metropolitan Atlanta Congenital Defects Program (MACDP), the oldest population-based birth defects surveillance system in the United States with active case ascertainment. For the period 1978-2005, CDC assessed the overall prevalence of major birth defects and their frequency relative to selected maternal and infant characteristics. The MACDP results indicated that the prevalence of major birth defects in metropolitan Atlanta, Georgia, remained stable during 1978-2005 but varied by maternal age and race/ethnicity, birthweight, and gestational age. Tracking the overall prevalence of major birth defects can identify subgroups that are affected disproportionately; additional measures focused on these subgroups might improve preconception care and care during pregnancy to prevent birth defects.
Similar articles
-
Evaluation of selected characteristics of pregnancy drug registries.Teratology. 1999 Dec;60(6):356-64. doi: 10.1002/(SICI)1096-9926(199912)60:6<356::AID-TERA8>3.0.CO;2-B. Teratology. 1999. PMID: 10590397
-
Including prenatal diagnoses in birth defects monitoring: Experience of the Metropolitan Atlanta Congenital Defects Program.Birth Defects Res A Clin Mol Teratol. 2009 Jan;85(1):20-9. doi: 10.1002/bdra.20508. Birth Defects Res A Clin Mol Teratol. 2009. PMID: 19089857
-
Improved national prevalence estimates for 18 selected major birth defects--United States, 1999-2001.MMWR Morb Mortal Wkly Rep. 2006 Jan 6;54(51):1301-5. MMWR Morb Mortal Wkly Rep. 2006. PMID: 16397457
-
Epidemiologic approaches to identifying environmental causes of birth defects.Am J Med Genet C Semin Med Genet. 2004 Feb 15;125C(1):4-11. doi: 10.1002/ajmg.c.30000. Am J Med Genet C Semin Med Genet. 2004. PMID: 14755428 Review.
-
Clinical geneticists in birth defects surveillance and epidemiology research programs: past, present and future roles.Birth Defects Res A Clin Mol Teratol. 2009 Jan;85(1):69-75. doi: 10.1002/bdra.20548. Birth Defects Res A Clin Mol Teratol. 2009. PMID: 19107957 Review.
Cited by
-
Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services.BMJ Open. 2024 Apr 24;14(4):e083550. doi: 10.1136/bmjopen-2023-083550. BMJ Open. 2024. PMID: 38663923 Free PMC article.
-
Gastrulation-stage gene expression in Nipbl+/- mouse embryos foreshadows the development of syndromic birth defects.Sci Adv. 2024 Mar 22;10(12):eadl4239. doi: 10.1126/sciadv.adl4239. Epub 2024 Mar 20. Sci Adv. 2024. PMID: 38507484 Free PMC article.
-
Recognition of Genetic Conditions After Learning With Images Created Using Generative Artificial Intelligence.JAMA Netw Open. 2024 Mar 4;7(3):e242609. doi: 10.1001/jamanetworkopen.2024.2609. JAMA Netw Open. 2024. PMID: 38488790 Free PMC article.
-
Prdm15 acts upstream of Wnt4 signaling in anterior neural development of Xenopus laevis.Front Cell Dev Biol. 2024 Feb 20;12:1316048. doi: 10.3389/fcell.2024.1316048. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38444828 Free PMC article.
-
Placental transfer of tofacitinib in the ex vivo dual-side human placenta perfusion model.Curr Res Toxicol. 2024 Jan 8;6:100149. doi: 10.1016/j.crtox.2024.100149. eCollection 2024. Curr Res Toxicol. 2024. PMID: 38292667 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical